Microglia P2X4 receptors as pharmacological targets for demyelinating diseases

Pharmacological activation of the P2X4 receptor expressed by brain microglia may provide a novel avenue to promote remyelination and improve clinical symptoms in experimental autoimmune encephalomyelitis and potentially in multiple sclerosis.

Detalles Bibliográficos
Autores principales: Di Virgilio, Francesco, Sarti, Alba Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079532/
https://www.ncbi.nlm.nih.gov/pubmed/30037978
http://dx.doi.org/10.15252/emmm.201809369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079532/
https://www.ncbi.nlm.nih.gov/pubmed/30037978
http://dx.doi.org/10.15252/emmm.201809369

Ejemplares similares